Procedure | Visit 1 | Visit 2 | Visit 3 | Visits 4–8 |
Screening | Baseline | Month 1 | Months 6–60 | |
Eligibility criteria | × | |||
Research participants’ consent | × | |||
Individual information | ||||
Demographic variables | × | |||
Menstrual history | × | |||
Marital history | × | |||
Personal hygiene behaviour | × | |||
Gynaecological examinations | × | |||
HPV knowledge | × | |||
HPV infection | × | |||
Regular examination | × | |||
HPV vaccination | × | |||
Physicians’ knowledge regarding treatment | × | |||
Partner information | × | |||
Outcomes | ||||
Primary outcome | ||||
Treatment patterns | × | × | ||
Secondary outcomes | ||||
HPV testing | × | × | ||
TCT | ○ | ○ | ||
Colposcopy | ○ | ○ | ||
Pathological examination | ○ | ○ | ||
Adverse events | ○ | ○ | ||
Other assessments | ||||
Intimate relationship satisfaction | × | × | ||
HIP | × | × | ||
Costs | × |
○, if applicable; HIP, HPV impact profile; HPV, human papillomavirus; TCT, Thin-prep liquid-based cytology test.